NG Industries Ltd

AGM details

• Date and mode: 26 Sep 2026 via VC/OAVM at 10:30 AM.
• Duration: 10:30–11:52 AM.

Resolutions

• Resolution 1: Adopt audited financial statements and reports.
• Resolution 2: Declare dividend of Rs 3.50 per equity share.
• Resolution 3: Reappoint Rajesh Goenka by rotation.

Voting results

• Resolution 1 passed by majority; some opposition.
• Resolution 2 passed by majority; no notable opposition.
• Resolution 3 passed by majority; some opposition.

Dividend

• Dividend per share approved: Rs 3.50.

Director changes

• Rajesh Goenka reappointed by rotation; term not specified.

Auditors

• No changes in auditors reported.

AGM details

• Date and time: 26 September 2026, 10:30 AM IST via VC/OAVM.
• Mode: Video Conferencing / Other Audio-Visual Means.
• Quorum: 30 shareholders including corporate representatives.
• Chairman: Rajesh Goenka (Chairman & Whole-time Director).

Ordinary resolutions

• Adoption of audited financial statements for year ended 31 March 2026 (Ordinary Resolution).
• Dividend of ₹3.50 per equity share declared (Ordinary Resolution).
• Re-appointment of Rajesh Goenka by rotation (Ordinary Resolution).

Voting results

• All ordinary resolutions passed by requisite majority.

Dividend details

• Dividend per share: ₹3.50; approved at AGM.

Director changes

• Rajesh Goenka re-appointed by rotation as Director.

NG Industries Ltd — Trading Window closed from 1 October 2026; will open 48 hours after the unaudited financial results for the quarter ended September 30, 2026.

Financial performance

• Revenue from operations: 163,948.31 thousand in FY2025-26.
• Revenue for FY2024-25: 165,468.56 thousand.
• Profit after tax: 17,337.65 thousand in FY2025-26.
• Profit after tax: 77,394.55 thousand in FY2024-25.
• EPS: 5.17 in FY2025-26; 23.10 in FY2024-25.
• Other income: 10,295.13 thousand in FY2025-26; 80,006.23 thousand in FY2024-25.
• Dividend per share: 3.50; proposed for FY2025-26.
• Short-term borrowings: 16,053.74 thousand; utilization ~3,909.06 thousand.

Dividends & CAPEX allocation

• Dividend proposed at 35% (₹3.50 per equity share).
• Final dividend for FY2024-25 already paid; no transfer to reserves.
• Unclaimed dividends and shares transferred to IEPF during the year.

Operations & strategy

• Integrated healthcare platform: clinics, diagnostic labs, indoor wards, dialysis, fertility, pharmacy.
• Dialysis services commenced in FY2025-26, expanding renal-care capability.
• Outlook: cautious, with gradual growth as conditions stabilise.
• Industry shifts: digital diagnostics, cashless insurance, value-based and home-based care.

Governance & controls

• Board of 4 directors; 2 independent; 1 woman director.
• NRC reconstituted Sept 28, 2024; 4 board meetings held in year.
• Statutory auditor: M.R. Singhwi & Co; Secretarial auditor: S. Rath & Co.
• Secretarial audit: no qualifications; no fraud reported.

CSR & sustainability

• CSR expenditure: ₹16.13 lakh; average net profit ₹828.90 lakh; 2% obligation.
• CSR project: free meals/education/healthcare via Sai Baba Seva Trust.
• CSR committee not constituted; functions discharged by the Board per CSR rules.

Capital structure & liquidity

• Short-term borrowings exist; details in Note 15.
• No long-term borrowings reported; cash flows align with operations.
• Share dematerialisation: 99.46% of shares in demat form; promoter holding dematerialised.

Shareholders information

• Annual General Meeting scheduled for 26 September 2026 via VC/OAVM.
• Dividend payout window: 28 Sep to 24 Oct 2026.
• PAN/KYC and investor documentation updates as per SEBI requirements.

Record date and voting rights

• Record date fixed at 19 September 2026 for dividend entitlement.
• Reckoning voting rights for remote e-voting and AGM e-voting.
• E-voting window: 23 September 2026, 9:00 AM to 25 September 2026, 5:00 PM.

Financials

• Total income from operations (net) for Q1 FY27: 458.11.
• Net Sales / Income from Operations (net of excise): 421.04.
• Other operating income: 20.61; Employee benefits: 66.68; Finance costs: 1.25; Depreciation: 12.36.
• Profit before tax: 39.41; Current tax: 11.00; Deferred tax: 0.44.
• Basic EPS: 1.16.

Operational & governance

• Company operates in a single business segment.
• Unaudited standalone results approved by Board on 13 Aug 2026.
• Limited Review on results conducted by M.R. Singhvi & Co.
• Previous year/quarter figures regrouped where necessary.